<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Hinge Health, Inc. (HNGE) on GreekSoup</title>
<link>https://greeksoup.ai/stocks/us/hnge/</link>
<description>Every dated entry in the public record on Hinge Health, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days.</description>
<language>en</language>
<atom:link href="https://greeksoup.ai/stocks/us/hnge/feed.xml" rel="self" type="application/rss+xml"/>
<lastBuildDate>Fri, 30 Oct 2026 00:00:00 +0000</lastBuildDate>
<item><title>Hinge Health, Inc.: short interest 6,309,855 shares at the 15 October 2026 settlement, 3.60 days to cover</title><link>https://greeksoup.ai/stocks/us/hnge/short-interest/</link><guid isPermaLink="false">us:HNGE:short-interest:2026-10-15:ec5835a44e</guid><pubDate>Thu, 15 Oct 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Insight Venture Partners X (Co-Investors), L.P. plans to sell 17,825 shares worth $1.9 million around 14 October 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-10-14:79b33b43cd</guid><pubDate>Wed, 14 Oct 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000197407826000382/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Insight Venture Partners (Delaware) X, L.P. plans to sell 118,822 shares worth $12.5 million around 14 October 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-10-14:d1b8a12efd</guid><pubDate>Wed, 14 Oct 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000197407826000381/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Insight Venture Partners (Cayman) X, L.P. plans to sell 614,262 shares worth $64.5 million around 14 October 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-10-14:e089e2b139</guid><pubDate>Wed, 14 Oct 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000197407826000379/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Insight Venture Partners X, L.P. plans to sell 749,091 shares worth $78.7 million around 14 October 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-10-14:3bb9c199e2</guid><pubDate>Wed, 14 Oct 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000197407826000380/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, JAMES BUDGE plans to sell 47,720 shares worth $4.9 million around 12 October 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-10-13:3a1580f1e3</guid><pubDate>Tue, 13 Oct 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000195004726010158/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, GABRIEL MECKLENBURG plans to sell 200,000 shares worth $20.6 million around 12 October 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-10-13:ee1e50e127</guid><pubDate>Tue, 13 Oct 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000195004726010159/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Budge James (Chief Financial Officer) sold 2,100 shares (under a trading plan set in advance) at $101.53 on 12 October 2026, $213,207</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-10-13:bef87ae2da</guid><pubDate>Tue, 13 Oct 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000133817626000038/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Budge James (Chief Financial Officer) sold 21,702 shares (under a trading plan set in advance) at $102.54 on 12 October 2026, $2.2 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-10-13:524520ed2c</guid><pubDate>Tue, 13 Oct 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000133817626000038/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Budge James (Chief Financial Officer) sold 14,498 shares (under a trading plan set in advance) at $103.48 on 12 October 2026, $1.5 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-10-13:2e06d2d21a</guid><pubDate>Tue, 13 Oct 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000133817626000038/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Budge James (Chief Financial Officer) sold 9,420 shares (under a trading plan set in advance) at $104.33 on 12 October 2026, $982,836</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-10-13:b285f85549</guid><pubDate>Tue, 13 Oct 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000133817626000038/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Mecklenburg Gabriel M.I. (Director) sold 8,642 shares (under a trading plan set in advance) at $101.53 on 12 October 2026, $877,429</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-10-13:c1b972437f</guid><pubDate>Tue, 13 Oct 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206278126000026/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Mecklenburg Gabriel M.I. (Director) sold 91,502 shares (under a trading plan set in advance) at $102.53 on 12 October 2026, $9.4 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-10-13:9df7e45f38</guid><pubDate>Tue, 13 Oct 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206278126000026/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Mecklenburg Gabriel M.I. (Director) sold 59,988 shares (under a trading plan set in advance) at $103.48 on 12 October 2026, $6.2 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-10-13:9045b73301</guid><pubDate>Tue, 13 Oct 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206278126000026/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Mecklenburg Gabriel M.I. (Director) sold 39,868 shares (under a trading plan set in advance) at $104.34 on 12 October 2026, $4.2 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-10-13:cf2c89a712</guid><pubDate>Tue, 13 Oct 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206278126000026/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Perez Daniel Antonio (CEO &amp; Co-Founder) sold 4,100 shares (under a trading plan set in advance) at $100.20 on 6 October 2026, $410,811</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-10-07:0dad420cb7</guid><pubDate>Wed, 07 Oct 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206323626000015/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, DANIEL PEREZ plans to sell 4,100 shares worth $403,235 around 6 October 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-10-06:49919a1fbf</guid><pubDate>Tue, 06 Oct 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000195004726010085/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Sloat Tyler (Director) took 175 shares in place of pay owed in cash (company plan, the filing does not say it was a choice) on 5 October 2026</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-10-06:63285d5643</guid><pubDate>Tue, 06 Oct 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000173543626000010/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Insight Venture Partners X (Co-Investors), L.P. plans to sell 11,587 shares worth $1.1 million around 30 September 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-09-30:c85c67ba02</guid><pubDate>Wed, 30 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000197407826000372/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Insight Venture Partners (Delaware) X, L.P. plans to sell 77,248 shares worth $7.6 million around 30 September 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-09-30:c18ab3d829</guid><pubDate>Wed, 30 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000197407826000371/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Insight Venture Partners (Cayman) X, L.P. plans to sell 399,338 shares worth $39.1 million around 30 September 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-09-30:12cc2aab43</guid><pubDate>Wed, 30 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000197407826000369/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Insight Venture Partners X, L.P. plans to sell 486,991 shares worth $47.7 million around 30 September 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-09-30:c0b67e4f66</guid><pubDate>Wed, 30 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000197407826000370/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: short interest 6,332,267 shares at the 30 September 2026 settlement, 3.33 days to cover</title><link>https://greeksoup.ai/stocks/us/hnge/short-interest/</link><guid isPermaLink="false">us:HNGE:short-interest:2026-09-30:121aa01cbc</guid><pubDate>Wed, 30 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Pursley James (President) sold 9,065 shares (under a trading plan set in advance) at $93.37 on 21 September 2026, $846,381</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-23:445928b3dc</guid><pubDate>Wed, 23 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000178310826000032/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Pursley James (President) sold 23,135 shares (under a trading plan set in advance) at $94.40 on 21 September 2026, $2.2 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-23:190a7a82df</guid><pubDate>Wed, 23 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000178310826000032/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Pursley James (President) sold 800 shares (under a trading plan set in advance) at $95.10 on 21 September 2026, $76,077</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-23:b0fbd33f83</guid><pubDate>Wed, 23 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000178310826000032/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, JAMES PURSLEY plans to sell 33,000 shares worth $3.1 million around 21 September 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-09-21:cc71d28206</guid><pubDate>Mon, 21 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000195004726009703/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Robinson Elliott (Director), see footnote, sold 0 shares at $0.00 on 14 September 2026, $0</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-16:572d5004aa</guid><pubDate>Wed, 16 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000119312526393293/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Mecklenburg Gabriel M.I. (Director) sold 2,800 shares (under a trading plan set in advance) at $88.98 on 14 September 2026, $249,142</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-15:894f5b69b4</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206278126000024/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Mecklenburg Gabriel M.I. (Director) sold 11,700 shares (under a trading plan set in advance) at $91.09 on 14 September 2026, $1.1 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-15:af3a73807f</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206278126000024/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Mecklenburg Gabriel M.I. (Director) sold 16,540 shares (under a trading plan set in advance) at $91.92 on 14 September 2026, $1.5 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-15:c91e008846</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206278126000024/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Mecklenburg Gabriel M.I. (Director) sold 56,161 shares (under a trading plan set in advance) at $93.00 on 14 September 2026, $5.2 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-15:f5174ad014</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206278126000024/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Mecklenburg Gabriel M.I. (Director) sold 33,501 shares (under a trading plan set in advance) at $94.03 on 14 September 2026, $3.2 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-15:9685f4f4de</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206278126000024/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Mecklenburg Gabriel M.I. (Director) sold 29,298 shares (under a trading plan set in advance) at $94.70 on 14 September 2026, $2.8 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-15:440448f5f2</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206278126000024/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: short interest 4,830,410 shares at the 15 September 2026 settlement, 2.65 days to cover</title><link>https://greeksoup.ai/stocks/us/hnge/short-interest/</link><guid isPermaLink="false">us:HNGE:short-interest:2026-09-15:784a9a9c5c</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Mecklenburg Gabriel M.I. (Director) sold 5,795 shares (under a trading plan set in advance) at $87.02 on 11 September 2026, $504,304</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-14:7c20e3c8a6</guid><pubDate>Mon, 14 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206278126000022/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Mecklenburg Gabriel M.I. (Director) sold 45,533 shares (under a trading plan set in advance) at $88.15 on 11 September 2026, $4.0 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-14:20cc462829</guid><pubDate>Mon, 14 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206278126000022/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Mecklenburg Gabriel M.I. (Director) sold 113,707 shares (under a trading plan set in advance) at $88.73 on 11 September 2026, $10.1 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-14:259ea5d837</guid><pubDate>Mon, 14 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206278126000022/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Mecklenburg Gabriel M.I. (Director) sold 73,241 shares (under a trading plan set in advance) at $89.77 on 11 September 2026, $6.6 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-14:16e8ca2a8c</guid><pubDate>Mon, 14 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206278126000022/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Mecklenburg Gabriel M.I. (Director) sold 11,724 shares (under a trading plan set in advance) at $90.46 on 11 September 2026, $1.1 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-14:0ae4328adb</guid><pubDate>Mon, 14 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206278126000022/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, GABRIEL MECKLENBURG plans to sell 400,000 shares worth $35.3 million around 11 September 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-09-11:0836603c83</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000195004726009348/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Budge James (Chief Financial Officer) sold 13,261 shares (under a trading plan set in advance) at $88.22 on 10 September 2026, $1.2 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:852ec8b868</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000133817626000034/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Budge James (Chief Financial Officer) sold 13,807 shares (under a trading plan set in advance) at $89.00 on 10 September 2026, $1.2 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:c4c2a7919d</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000133817626000034/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Budge James (Chief Financial Officer) sold 21,783 shares (under a trading plan set in advance) at $90.05 on 10 September 2026, $2.0 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:1595ebf89f</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000133817626000034/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Budge James (Chief Financial Officer) sold 5,910 shares (under a trading plan set in advance) at $90.76 on 10 September 2026, $536,403</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:7c7146af10</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000133817626000034/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Budge James (Chief Financial Officer) sold 800 shares (under a trading plan set in advance) at $91.62 on 10 September 2026, $73,294</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:0ab4fa4c62</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000133817626000034/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Perez Daniel Antonio (CEO &amp; Co-Founder) sold 24,390 shares (under a trading plan set in advance) at $88.22 on 10 September 2026, $2.2 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:d2d2a86ef3</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206323626000014/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Perez Daniel Antonio (CEO &amp; Co-Founder) sold 24,599 shares (under a trading plan set in advance) at $89.02 on 10 September 2026, $2.2 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:4969c2ebaa</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206323626000014/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Perez Daniel Antonio (CEO &amp; Co-Founder) sold 42,740 shares (under a trading plan set in advance) at $90.09 on 10 September 2026, $3.9 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:4b1fd9c366</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206323626000014/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Perez Daniel Antonio (CEO &amp; Co-Founder) sold 7,171 shares (under a trading plan set in advance) at $90.95 on 10 September 2026, $652,183</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:71fc51b199</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206323626000014/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Perez Daniel Antonio (CEO &amp; Co-Founder) sold 1,100 shares (under a trading plan set in advance) at $91.60 on 10 September 2026, $100,759</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:1ae4f683b2</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206323626000014/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Perez Daniel Antonio (CEO &amp; Co-Founder), by Spouse, sold 37,251 shares (under a trading plan set in advance) at $88.22 on 10 September 2026, $3.3 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:db07cb3631</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206323626000014/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Perez Daniel Antonio (CEO &amp; Co-Founder), by Spouse, sold 35,303 shares (under a trading plan set in advance) at $89.01 on 10 September 2026, $3.1 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:dca3bdc19a</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206323626000014/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Perez Daniel Antonio (CEO &amp; Co-Founder), by Spouse, sold 58,076 shares (under a trading plan set in advance) at $90.03 on 10 September 2026, $5.2 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:2a49ab3fc9</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206323626000014/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Perez Daniel Antonio (CEO &amp; Co-Founder), by Spouse, sold 17,740 shares (under a trading plan set in advance) at $90.76 on 10 September 2026, $1.6 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:c7786fcd71</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206323626000014/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Perez Daniel Antonio (CEO &amp; Co-Founder), by Spouse, sold 1,630 shares (under a trading plan set in advance) at $91.60 on 10 September 2026, $149,308</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:2a4419f041</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000206323626000014/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Robinson Elliott (Director), see footnote, sold 0 shares at $0.00 on 9 September 2026, $0</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-11:9166753a06</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000119312526389521/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, JAMES BUDGE plans to sell 55,561 shares worth $5.1 million around 10 September 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-09-10:8e3ec3b0f1</guid><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000195004726009310/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, DANIEL PEREZ plans to sell 100,000 shares worth $9.1 million around 10 September 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-09-10:71ee71f03a</guid><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000195004726009309/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, SUTHASINI MOGUN plans to sell 150,000 shares worth $13.7 million around 10 September 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-09-10:f62843f0a1</guid><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000195004726009308/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Bessemer Venture Partners X Institutional LP plans to sell 242,100 shares worth $22.4 million around 9 September 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-09-09:da92aaee9e</guid><pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000162828026061185/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Bessemer Venture Partners X LP plans to sell 257,900 shares worth $23.9 million around 9 September 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-09-09:14aed9477a</guid><pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000162828026061183/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Robinson Elliott (Director), see footnote, sold 0 shares at $0.00 on 8 September 2026, $0</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-09:1da3dfdf57</guid><pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000119312526386693/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Robinson Elliott (Director), see footnote, sold 0 shares at $0.00 on 4 September 2026, $0</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-09:300d19f31b</guid><pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000119312526386693/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Robinson Elliott (Director), see footnote, sold 0 shares at $0.00 on 3 September 2026, $0</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-04:1fe09125d1</guid><pubDate>Fri, 04 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000119312526383894/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Robinson Elliott (Director), see footnote, sold 0 shares at $0.00 on 2 September 2026, $0</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-09-04:a6177e1a28</guid><pubDate>Fri, 04 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000119312526383894/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Michael Triplett 2012 Irrevocable Trust. plans to sell 13,774 shares worth $1.2 million around 3 September 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-09-03:292f8aafce</guid><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000197407826000342/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Jeffrey Lieberman 2012 Family Trust plans to sell 297 shares worth $26,730 around 1 September 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-09-01:498ae07456</guid><pubDate>Tue, 01 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000197407826000340/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, JL 2025 Family Trust LLC plans to sell 8,382 shares worth $754,380 around 1 September 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-09-01:cddc8e5a1b</guid><pubDate>Tue, 01 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000197407826000341/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Lieberman Jeffrey plans to sell 11,204 shares worth $1.0 million around 1 September 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-09-01:8d2406e390</guid><pubDate>Tue, 01 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000197407826000339/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: short interest 5,439,387 shares at the 31 August 2026 settlement, 2.96 days to cover</title><link>https://greeksoup.ai/stocks/us/hnge/short-interest/</link><guid isPermaLink="false">us:HNGE:short-interest:2026-08-31:70c7ffc793</guid><pubDate>Mon, 31 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Triplett Thomas Michael plans to sell 66,967 shares worth $6.0 million around 8 August 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-08-28:a0d3e5a82a</guid><pubDate>Fri, 28 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000197407826000336/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Robinson Elliott (Director), see footnote, sold 0 shares at $0.00 on 26 August 2026, $0</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-08-27:b4f0f9e83e</guid><pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000119312526371548/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Robinson Elliott (Director), see footnote, sold 0 shares at $0.00 on 25 August 2026, $0</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-08-27:b05385b66d</guid><pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000119312526371548/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Bessemer Venture Partners X Institutional LP plans to sell 121,050 shares worth $10.9 million around 25 August 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-08-25:7193f370b4</guid><pubDate>Tue, 25 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000162828026058951/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Bessemer Venture Partners X LP plans to sell 128,950 shares worth $11.6 million around 25 August 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-08-25:9a42f49f02</guid><pubDate>Tue, 25 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000162828026058950/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Pursley James (President) sold 500 shares (under a trading plan set in advance) at $84.80 on 21 August 2026, $42,401</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-08-24:597670292b</guid><pubDate>Mon, 24 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000178310826000028/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Pursley James (President) sold 6,300 shares (under a trading plan set in advance) at $87.23 on 21 August 2026, $549,559</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-08-24:c91ff4fdfe</guid><pubDate>Mon, 24 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000178310826000028/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Pursley James (President) sold 22,789 shares (under a trading plan set in advance) at $88.25 on 21 August 2026, $2.0 million</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-08-24:d9527e5623</guid><pubDate>Mon, 24 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000178310826000028/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Pursley James (President) sold 3,411 shares (under a trading plan set in advance) at $88.68 on 21 August 2026, $302,492</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-08-24:8f9ff27b88</guid><pubDate>Mon, 24 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000178310826000028/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc. filed 8-K: material agreement, new financial obligation</title><link>https://greeksoup.ai/stocks/us/hnge/filings/</link><guid isPermaLink="false">us:HNGE:filing:2026-08-21:12f9acab64</guid><pubDate>Fri, 21 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000162828026058439/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Leslie Kristina M (Director) sold 1,200 shares at $88.23 on 20 August 2026, $105,876</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-08-21:2083e45e72</guid><pubDate>Fri, 21 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000130720726000005/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Robinson Elliott (Director), see footnote, sold 0 shares at $0.00 on 19 August 2026, $0</title><link>https://greeksoup.ai/stocks/us/hnge/insiders/</link><guid isPermaLink="false">us:HNGE:insider:2026-08-21:7e9bb01aa8</guid><pubDate>Fri, 21 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000119312526361316/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, KRISTINA LESLIE plans to sell 1,200 shares worth $105,876 around 20 August 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-08-20:c2b1a34054</guid><pubDate>Thu, 20 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000195004726008492/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Bessemer Venture Partners X Institutional LP plans to sell 121,050 shares worth $10.4 million around 19 August 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-08-19:c5139a3f3d</guid><pubDate>Wed, 19 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000162828026057989/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Form 144, Bessemer Venture Partners X LP plans to sell 128,950 shares worth $11.1 million around 19 August 2026</title><link>https://greeksoup.ai/stocks/us/hnge/planned-sales/</link><guid isPermaLink="false">us:HNGE:planned-sale:2026-08-19:6b3541daee</guid><pubDate>Wed, 19 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000162828026057987/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Schedule 13G/A filed by Bessemer Venture Partners X L.P., 3.0% of the class</title><link>https://greeksoup.ai/stocks/us/hnge/holders/</link><guid isPermaLink="false">us:HNGE:schedule-13:2026-08-14:1cc15dd043</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000119312526352284/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/holders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Schedule 13G/A filed by Insight Venture Partners X, LP, 9.4% of the class</title><link>https://greeksoup.ai/stocks/us/hnge/holders/</link><guid isPermaLink="false">us:HNGE:schedule-13:2026-08-14:472a1c20c6</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000089914026000890/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/holders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: short interest 5,626,572 shares at the 14 August 2026 settlement, 2.74 days to cover</title><link>https://greeksoup.ai/stocks/us/hnge/short-interest/</link><guid isPermaLink="false">us:HNGE:short-interest:2026-08-14:ca45e5367b</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc.: Schedule 13G/A filed by 11.2 Capital I, L.P., 4.0% of the class</title><link>https://greeksoup.ai/stocks/us/hnge/holders/</link><guid isPermaLink="false">us:HNGE:schedule-13:2026-08-13:0c1a1cb9eb</guid><pubDate>Thu, 13 Aug 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000159133626000006/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/holders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc. Q2 FY2026 results: revenue $213 million, net income $44 million</title><link>https://greeksoup.ai/stocks/us/hnge/results/fy2026-q2/</link><guid isPermaLink="false">us:HNGE:result:2026-08-06:0f39d093be</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>Results</category><description><![CDATA[<p>Results. <a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001673743&amp;type=10-&amp;dateb=&amp;owner=include&amp;count=40">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/results/fy2026-q2/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc. filed 10-Q: 10-q</title><link>https://greeksoup.ai/stocks/us/hnge/filings/</link><guid isPermaLink="false">us:HNGE:filing:2026-08-06:23ce2583e4</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000162828026054327/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Hinge Health, Inc. filed 8-K: results of operations, regulation fd disclosure, other events</title><link>https://greeksoup.ai/stocks/us/hnge/filings/</link><guid isPermaLink="false">us:HNGE:filing:2026-08-04:bb7c0b3e2c</guid><pubDate>Tue, 04 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1673743/000162828026052558/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/hnge/filings/">The page on GreekSoup</a>.</p>]]></description></item>
</channel>
</rss>
